Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Patient-Defined Goals and Preferences Among Adults With Advanced Neuroendocrine TumorsDaneng Li, Can-Lan Sun, Heeyoung Kim, et al.Geroscience|May 8, 2026
Epigenetic age acceleration measures and chemotoxicity in older adults with early breast cancerJingran Ji, Can-Lan Sun, William Dale, et al.Journal of Geriatric Oncology|October 12, 2017
A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in MexicoEnrique Soto-Perez-De-Celis, Heeyoung Kim, María Patricia Rojo-Castillo, et al.Journal of Geriatric Oncology|October 20, 2020
Geriatric Oncology Workshop (GrOW): Development and Evaluation of a Nationwide Nursing CurriculumPeggy Burhenn, Denice Economou, Carolina Uranga, et al.Journal of Geriatric Oncology|August 8, 2026
Geriatric Assessment-guided INtervention with Supportive Care (GAIN-S): A telehealth quality improvement study in a lower-resourced communityTanyanika Phillips, Can-Lan Sun, Leana Cabrera Chien, et al.Frontiers in Immunology|March 21, 2022
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis PatientsLouise Benning, Katrin Klein, Christian Morath, et al.Viruses|August 26, 2023
BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort StudyClaudius Speer, Maximilian Töllner, Louise Benning, et al.Cancer|January 25, 2020
Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumorsEfrat Dotan, William P Tew, Supriya G Mohile, et al.Journal of Medical Virology|February 16, 2023
Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infectionMaximilian Stich, Louise Benning, Claudius Speer, et al.ACS Infectious Diseases|February 11, 2021
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19Kas Steuten, Heeyoung Kim, John C Widen, et al.Pageof 12